Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
RXO Quote, Financials, Valuation and Earnings
Last price:
$16.63
Seasonality move
:
-6.13%
Day range:
$15.77 - $16.50
52-week range:
$12.19 - $32.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.47x
P/B ratio:
1.67x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-45.83%
Market cap:
$2.6B
Revenue:
$4.6B
EPS (TTM):
-$2.17
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $4.7B | $4.8B | $3.9B | $4.6B | |
| Revenue Growth (YoY) | 6.88% | 39.68% | 2.28% | -18.12% | 15.87% | |
| Cost of Revenues | $2.8B | $4B | $3.9B | $3.3B | $3.9B | |
| Gross Profit | $539M | $735M | $860M | $658M | $696M | |
| Gross Profit Margin | 16.06% | 15.68% | 17.93% | 16.76% | 15.3% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $455M | $539M | $640M | $591M | $666M | |
| Other Inc / (Exp) | -$27M | -$5M | -$97M | -$31M | -$304M | |
| Operating Expenses | $455M | $539M | $640M | $591M | $666M | |
| Operating Income | $84M | $196M | $220M | $67M | $30M | |
| Net Interest Expenses | -- | -- | $4M | $32M | $30M | |
| EBT. Incl. Unusual Items | $57M | $191M | $119M | $4M | -$304M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14M | $41M | $27M | -- | -$14M | |
| Net Income to Company | $43M | $150M | $92M | $4M | -$290M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $43M | $150M | $92M | $4M | -$290M | |
| Basic EPS (Cont. Ops) | $0.37 | $1.30 | $0.80 | $0.03 | -$2.17 | |
| Diluted EPS (Cont. Ops) | $0.37 | $1.30 | $0.79 | $0.03 | -$2.17 | |
| Weighted Average Basic Share | $115.1M | $115.1M | $115.3M | $116.9M | $133.4M | |
| Weighted Average Diluted Share | $115.1M | $115.1M | $115.8M | $119.5M | $133.4M | |
| EBITDA | $133M | $272M | $209M | $103M | -$187M | |
| EBIT | $57M | $191M | $123M | $36M | -$274M | |
| Revenue (Reported) | $3.4B | $4.7B | $4.8B | $3.9B | $4.6B | |
| Operating Income (Reported) | $84M | $196M | $220M | $67M | $30M | |
| Operating Income (Adjusted) | $57M | $191M | $123M | $36M | -$274M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $1.3B | $1B | $913M | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -23.02% | -9.6% | 56.96% | |
| Cost of Revenues | -- | $1.1B | $838M | $768M | $1.2B | |
| Gross Profit | -- | $215M | $172M | $145M | $200M | |
| Gross Profit Margin | -- | 16.39% | 17.03% | 15.88% | 13.96% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $161M | $153M | $145M | $210M | |
| Other Inc / (Exp) | -- | -$3M | -$14M | -$13M | -$20M | |
| Operating Expenses | -- | $161M | $153M | $145M | $210M | |
| Operating Income | -- | $54M | $19M | -- | -$10M | |
| Net Interest Expenses | -- | -- | $8M | $8M | $9M | |
| EBT. Incl. Unusual Items | -- | $51M | -$3M | -$21M | -$39M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $12M | -$3M | -$6M | -$8M | |
| Net Income to Company | -- | $39M | -- | -$15M | -$31M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $39M | -- | -$15M | -$31M | |
| Basic EPS (Cont. Ops) | -- | $0.34 | -- | -$0.13 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -- | $0.34 | -- | -$0.13 | -$0.18 | |
| Weighted Average Basic Share | -- | $115.1M | $116.6M | $117.2M | $168M | |
| Weighted Average Diluted Share | -- | $115.1M | $119.4M | $117.2M | $168M | |
| EBITDA | -- | $72M | $23M | $3M | $2M | |
| EBIT | -- | $51M | $5M | -$13M | -$30M | |
| Revenue (Reported) | -- | $1.3B | $1B | $913M | $1.4B | |
| Operating Income (Reported) | -- | $54M | $19M | -- | -$10M | |
| Operating Income (Adjusted) | -- | $51M | $5M | -$13M | -$30M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $4.9B | $4.5B | $3.8B | $5.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $4.2B | $3.7B | $3.2B | $4.3B | |
| Gross Profit | -- | $764M | $817M | $631M | $751M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $567M | $632M | $583M | $731M | |
| Other Inc / (Exp) | -- | -$5M | -$108M | -$30M | -$311M | |
| Operating Expenses | -- | $567M | $632M | $583M | $731M | |
| Operating Income | -- | $197M | $185M | $48M | $20M | |
| Net Interest Expenses | -- | -- | $12M | $32M | $31M | |
| EBT. Incl. Unusual Items | -- | $192M | $65M | -$14M | -$322M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $43M | $12M | -$3M | -$16M | |
| Net Income to Company | -- | -- | $53M | -$11M | -$306M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $149M | $53M | -$11M | -$306M | |
| Basic EPS (Cont. Ops) | -- | $1.29 | $0.47 | -$0.09 | -$2.17 | |
| Diluted EPS (Cont. Ops) | -- | $1.29 | $0.47 | -$0.09 | -$2.17 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | $251M | $137M | $83M | -$188M | |
| EBIT | -- | $189M | $54M | $18M | -$291M | |
| Revenue (Reported) | -- | $4.9B | $4.5B | $3.8B | $5.1B | |
| Operating Income (Reported) | -- | $197M | $185M | $48M | $20M | |
| Operating Income (Adjusted) | -- | $189M | $54M | $18M | -$291M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $1.3B | $1B | $913M | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.1B | $838M | $768M | $1.2B | |
| Gross Profit | -- | $215M | $172M | $145M | $200M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $161M | $153M | $145M | $210M | |
| Other Inc / (Exp) | -- | -$3M | -$14M | -$13M | -$20M | |
| Operating Expenses | -- | $161M | $153M | $145M | $210M | |
| Operating Income | -- | $54M | $19M | -- | -$10M | |
| Net Interest Expenses | -- | -- | $8M | $8M | $9M | |
| EBT. Incl. Unusual Items | -- | $51M | -$3M | -$21M | -$39M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $12M | -$3M | -$6M | -$8M | |
| Net Income to Company | -- | $39M | -- | -$15M | -$31M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $39M | -- | -$15M | -$31M | |
| Basic EPS (Cont. Ops) | -- | $0.34 | -- | -$0.13 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -- | $0.34 | -- | -$0.13 | -$0.18 | |
| Weighted Average Basic Share | -- | $115.1M | $116.6M | $117.2M | $168M | |
| Weighted Average Diluted Share | -- | $115.1M | $119.4M | $117.2M | $168M | |
| EBITDA | -- | $72M | $23M | $3M | $2M | |
| EBIT | -- | $51M | $5M | -$13M | -$30M | |
| Revenue (Reported) | -- | $1.3B | $1B | $913M | $1.4B | |
| Operating Income (Reported) | -- | $54M | $19M | -- | -$10M | |
| Operating Income (Adjusted) | -- | $51M | $5M | -$13M | -$30M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $70M | $29M | $98M | $5M | $35M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $772M | $1B | $900M | $743M | $1.2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $20M | $44M | $31M | $48M | $77M | |
| Total Current Assets | $862M | $1.1B | $1B | $796M | $1.3B | |
| Property Plant And Equipment | $236M | $239M | $278M | $319M | $411M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $630M | $630M | $630M | $630M | $1.1B | |
| Other Intangibles | $124M | $100M | $79M | $68M | $499M | |
| Other Long-Term Assets | $18M | $16M | $15M | $12M | $42M | |
| Total Assets | $1.9B | $2.1B | $2B | $1.8B | $3.4B | |
| Accounts Payable | $390M | $520M | $501M | $414M | $568M | |
| Accrued Expenses | $204M | $248M | $256M | $199M | $373M | |
| Current Portion Of Long-Term Debt | -- | -- | $4M | $3M | $17M | |
| Current Portion Of Capital Lease Obligations | $30M | $42M | $48M | $53M | $81M | |
| Other Current Liabilities | $5M | $6M | $14M | $13M | $26M | |
| Total Current Liabilities | $629M | $816M | $823M | $682M | $1.1B | |
| Long-Term Debt | -- | -- | $451M | $356M | $351M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $802M | $998M | $1.4B | $1.2B | $1.8B | |
| Common Stock | -- | -- | $1M | $1M | $2M | |
| Other Common Equity Adj | -$2M | -$2M | -$4M | -$3M | -$10M | |
| Common Equity | $1.1B | $1.1B | $587M | $594M | $1.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.1B | $1.1B | $587M | $594M | $1.6B | |
| Total Liabilities and Equity | $1.9B | $2.1B | $2B | $1.8B | $3.4B | |
| Cash and Short Terms | $70M | $29M | $98M | $5M | $35M | |
| Total Debt | -- | -- | $455M | $359M | $368M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $121M | $7M | $16M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $862M | $716M | $1.2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $46M | $47M | $89M | |
| Total Current Assets | -- | -- | $1B | $770M | $1.3B | |
| Property Plant And Equipment | -- | -- | $269M | $321M | $399M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $630M | $630M | $1.1B | |
| Other Intangibles | -- | -- | $76M | $65M | $484M | |
| Other Long-Term Assets | -- | -- | $14M | $13M | $42M | |
| Total Assets | -- | -- | $2B | $1.8B | $3.3B | |
| Accounts Payable | -- | -- | $496M | $372M | $498M | |
| Accrued Expenses | -- | -- | $265M | $220M | $358M | |
| Current Portion Of Long-Term Debt | -- | -- | $4M | $16M | $17M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $46M | $54M | $80M | |
| Other Current Liabilities | -- | -- | $9M | $12M | $11M | |
| Total Current Liabilities | -- | -- | $820M | $674M | $964M | |
| Long-Term Debt | -- | -- | $451M | $351M | $387M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $1.4B | $1.2B | $1.7B | |
| Common Stock | -- | -- | $1M | $1M | $2M | |
| Other Common Equity Adj | -- | -- | -$4M | -$3M | -$8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $585M | $582M | $1.6B | |
| Total Liabilities and Equity | -- | -- | $2B | $1.8B | $3.3B | |
| Cash and Short Terms | -- | -- | $121M | $7M | $16M | |
| Total Debt | -- | -- | $455M | $367M | $404M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $43M | $150M | $92M | $4M | -$290M | |
| Depreciation & Amoritzation | $76M | $81M | $86M | $67M | $87M | |
| Stock-Based Compensation | $8M | $8M | $32M | $19M | $23M | |
| Change in Accounts Receivable | -$264M | -$242M | $92M | $158M | -$109M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $25M | $155M | $310M | $89M | -$12M | |
| Capital Expenditures | $47M | $39M | $57M | $64M | $45M | |
| Cash Acquisitions | -- | -- | -- | -- | -$1B | |
| Cash From Investing | -$39M | -$38M | -$56M | -$66M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $451M | $76M | $238M | |
| Long-Term Debt Repaid | -- | -- | -- | -$175M | -$229M | |
| Repurchase of Common Stock | -- | -- | -- | -$2M | -- | |
| Other Financing Activities | $32M | -$158M | -$634M | -$16M | -$26M | |
| Cash From Financing | $32M | -$158M | -$183M | -$117M | $1.1B | |
| Beginning Cash (CF) | $51M | $70M | $29M | $98M | $5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18M | -$41M | $71M | -$94M | $32M | |
| Ending Cash (CF) | $70M | $29M | $98M | $5M | $35M | |
| Levered Free Cash Flow | -$22M | $116M | $253M | $25M | -$57M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $39M | -- | -$15M | -$31M | |
| Depreciation & Amoritzation | -- | $21M | $18M | $16M | $32M | |
| Stock-Based Compensation | -- | $2M | $5M | $5M | $7M | |
| Change in Accounts Receivable | -- | -$210M | $40M | $27M | $76M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $103M | $42M | $7M | -$2M | |
| Capital Expenditures | -- | $12M | $12M | $11M | $15M | |
| Cash Acquisitions | -- | -- | -- | -- | -$10M | |
| Cash From Investing | -- | -$12M | -$12M | -$11M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $39M | $300M | |
| Long-Term Debt Repaid | -- | -- | -- | -$31M | -$265M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$74M | -$8M | -$2M | -$28M | |
| Cash From Financing | -- | -$74M | -$8M | $6M | $7M | |
| Beginning Cash (CF) | -- | $29M | $98M | $5M | $35M | |
| Foreign Exchange Rate Adjustment | -- | -- | $1M | -- | $1M | |
| Additions / Reductions | -- | $17M | $22M | $2M | -$20M | |
| Ending Cash (CF) | -- | $46M | $121M | $7M | $16M | |
| Levered Free Cash Flow | -- | $91M | $30M | -$4M | -$17M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $53M | -$11M | -$306M | |
| Depreciation & Amoritzation | -- | -- | $83M | $65M | $103M | |
| Stock-Based Compensation | -- | $2M | $35M | $19M | $25M | |
| Change in Accounts Receivable | -- | -- | $342M | $145M | -$60M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $249M | $54M | -$21M | |
| Capital Expenditures | -- | $12M | $57M | $63M | $49M | |
| Cash Acquisitions | -- | -- | -- | -- | -$1B | |
| Cash From Investing | -- | -- | -$56M | -$65M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $115M | $499M | |
| Long-Term Debt Repaid | -- | -- | -- | -$206M | -$463M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$568M | -$10M | -$52M | |
| Cash From Financing | -- | -- | -$117M | -$103M | $1.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $76M | -$114M | $10M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $192M | -$9M | -$70M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $39M | -- | -$15M | -$31M | |
| Depreciation & Amoritzation | -- | $21M | $18M | $16M | $32M | |
| Stock-Based Compensation | -- | $2M | $5M | $5M | $7M | |
| Change in Accounts Receivable | -- | -$210M | $40M | $27M | $76M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $103M | $42M | $7M | -$2M | |
| Capital Expenditures | -- | $12M | $12M | $11M | $15M | |
| Cash Acquisitions | -- | -- | -- | -- | -$10M | |
| Cash From Investing | -- | -$12M | -$12M | -$11M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $39M | $300M | |
| Long-Term Debt Repaid | -- | -- | -- | -$31M | -$265M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$74M | -$8M | -$2M | -$28M | |
| Cash From Financing | -- | -$74M | -$8M | $6M | $7M | |
| Beginning Cash (CF) | -- | $29M | $98M | $5M | $35M | |
| Foreign Exchange Rate Adjustment | -- | -- | $1M | -- | $1M | |
| Additions / Reductions | -- | $17M | $22M | $2M | -$20M | |
| Ending Cash (CF) | -- | $46M | $121M | $7M | $16M | |
| Levered Free Cash Flow | -- | $91M | $30M | -$4M | -$17M | |
Get RXO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RXO
Sector
P/E ratio
--
18.58x
PEG ratio
0.00x
0.25x
P/B ratio
1.67x
1.75x
Price / LTM sales
0.47x
0.94x
Growth Metrics
RXO
Sector
Revenue growth
56.96%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
7.69%
4.35%
Earnings forecast
$0.03
$0.40
Profitability
RXO
Sector
Profitability FY 2024
$696M
$393.9M
Return on invested capital
-19.36%
5.32%
Return on assets
-11.15%
3.49%
Return on equity
-25.45%
8.55%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
RXO
Sector
Total cash
$16M
$154.3M
Short term investments
--
$35.5M
Total assets
$3.4B
$1.7B
Long term debt
$404M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
